{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:00:11Z","timestamp":1790953211276,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011412.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:00:00Z","timestamp":1513296000000}}],"reference-count":251,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011412.pub3","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T18:16:21Z","timestamp":1515003381000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data"],"prefix":"10.1002","volume":"2017","author":[{"given":"Sarah J","family":"Nevitt","sequence":"first","affiliation":[{"name":"University of Liverpool; Department of Biostatistics; Block F, Waterhouse Building 1-5 Brownlow Hill Liverpool UK L69 3GL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sudell","sequence":"additional","affiliation":[{"name":"University of Liverpool; Department of Biostatistics; Block F, Waterhouse Building 1-5 Brownlow Hill Liverpool UK L69 3GL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Weston","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Fazakerley Liverpool Merseyside UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Tudur Smith","sequence":"additional","affiliation":[{"name":"University of Liverpool; Department of Biostatistics; Block F, Waterhouse Building 1-5 Brownlow Hill Liverpool UK L69 3GL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Fazakerley Liverpool Merseyside UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0920-1211(92)90099-F","article-title":"Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up","volume":"11","author":"Aikia","year":"1992","journal-title":"Epilepsy Research"},{"issue":"7605","key":"10.1002\/14651858.CD011412.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.39022.436389.BE","article-title":"Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial","volume":"334","author":"Banu","year":"2007","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(12)70105-9","article-title":"Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"11","author":"Baulac","year":"2012","journal-title":"Lancet Neurology"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD011412.pub3-BIB0004|cit4","first-page":"167. Abstract n","article-title":"Comparison of the effects of phenobarbital versus carbamazepine as single drug therapy in partial seizure with secondary generalization in children","volume":"50","author":"Bidabadi","year":"2009","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-1211(97)00024-7","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy","volume":"27","author":"Bill","year":"1997","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/08830738030180021701","article-title":"Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial","volume":"18","author":"Biton","year":"2003","journal-title":"Journal of Child Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","article-title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","volume":"56","author":"Biton","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/ebeh.2000.0143","article-title":"Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate","volume":"2","author":"Edwards","year":"2001","journal-title":"Epilepsy & Behavior"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1525-5050(02)00046-X","article-title":"Lamotrigine monotherapy improves health-related quality of life in epilepsy: a double-blind comparison with valproate","volume":"3","author":"Sackellares","year":"2002","journal-title":"Epilepsy & Behavior"},{"issue":"8948","key":"10.1002\/14651858.CD011412.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine\/Carbamazepine Monotherapy Trial Group","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/seiz.2000.0428","article-title":"A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure","volume":"9","author":"Gillham","year":"2000","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0012|cit12","first-page":"149","article-title":"Efficacy and safety of lamotrigine monotherapy in partial epilepsy","volume":"86-7","author":"Severi","year":"1994","journal-title":"Bollettino - Lega Italiana Contro L'Epilessia"},{"issue":"8948","key":"10.1002\/14651858.CD011412.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine\/Carbamazepine Monotherapy Trial Group","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/seiz.2000.0428","article-title":"A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure","volume":"9","author":"Gillham","year":"2000","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0015|cit15","first-page":"149","article-title":"Efficacy and safety of Lamotrigine monotherapy in partial epilepsy","volume":"86-7","author":"Severi","year":"1994","journal-title":"Bollettino - Lega Italiana Contro L'Epilessia"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(99)00039-X","article-title":"Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy: The UK Lamotrigine Elderly Study Group","volume":"37","author":"Brodie","year":"1999","journal-title":"Epilepsy Research"},{"issue":"9","key":"10.1002\/14651858.CD011412.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1528-1157.2002.45401.x","article-title":"Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy","volume":"43","author":"Brodie","year":"2002","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jnnp.48.7.639","article-title":"A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy","volume":"48","author":"Callaghan","year":"1985","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0020|cit20","first-page":"150","article-title":"Serum levels of sodium valproate, phenytoin and carbamazepine and seizure control in epilepsy","volume":"79","author":"Goggin","year":"1986","journal-title":"Irish Medical Journal"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0021|cit21","first-page":"203","article-title":"Randomised open trial of 35 subjects with epileptic seizures after stroke, treated with levetiracetam or carbamazepine CR","volume":"138","author":"Capone","year":"2008","journal-title":"Bollettino - Lega Italiana Contro L'Epilessia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0022|cit22","first-page":"235","article-title":"Event-related potentials (ERPS) in the evaluation of the effect of levetiracetam and carbamazepine on cognitive functions in adult newly diagnosed epileptic patients. Preliminary results of an opened randomised trial","volume":"138","author":"Castriota","year":"2008","journal-title":"Bollettino - Lega Italiana Contro L'Epilessia"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.51.5.1282","article-title":"A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77","volume":"51","author":"Chadwick","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0024|cit24","first-page":"185","article-title":"Gabapentin versus carbamazepine: monotherapy in newly-diagnosed patients with partial epilepsy: preliminary results","volume":"95-96","author":"Sasanelli","year":"1996","journal-title":"Bollettino - Lega Italiana Contro L'Epilessia"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1996.tb00516.x","article-title":"Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study","volume":"37","author":"Chen","year":"1996","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.seizure.2011.01.006","article-title":"The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy","volume":"20","author":"Cho","year":"2011","journal-title":"Seizure"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0920-1211(96)01013-3","article-title":"A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy","volume":"26","author":"Christe","year":"1997","journal-title":"Epilepsy Research"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000342669","article-title":"Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).","volume":"34","author":"Consoli","year":"2012","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0029|cit29","first-page":"377","article-title":"Short-term therapy with carbamazepine and phenobarbital: effects on cognitive functioning in temporal lobe epilepsy","volume":"45\/46","author":"Cossu","year":"1984","journal-title":"Bollettino Lega Italiana contro l'Epilessia"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1528-1157.1994.tb02448.x","article-title":"Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study","volume":"35","author":"Craig","year":"1994","journal-title":"Epilepsia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD011412.pub3-BIB0031|cit31","first-page":"62","article-title":"Multicenter comparative trial of valproate and phenytoin","volume":"35","author":"Tallis","year":"1994","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0033|cit32","first-page":"419","article-title":"Open randomized comparative trial of sodium valproate and carbamazepine in adult onset epilepsy","volume":"30","author":"Czapinski","year":"1996","journal-title":"Neurologia i Neurochirurgia Polska"},{"issue":"Suppl(3)","key":"10.1002\/14651858.CD011412.pub3-BIB0032|cit33","first-page":"42","article-title":"Randomised 36-month comparative study of valproic acid, phenytoin, phenobarbital and carbamazepine efficacy in patients with newly diagnosed epilepsy with partial complex seizures","volume":"38","author":"Czapinski","year":"1997","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Research"},{"issue":"9003","key":"10.1002\/14651858.CD011412.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(96)90074-4","article-title":"Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy","volume":"347","author":"Silva","year":"1996","journal-title":"Lancet"},{"issue":"Suppl Florence","key":"10.1002\/14651858.CD011412.pub3-BIB0036|cit36","first-page":"67","article-title":"A comparison of carbamazepine and oxcarbazepine in partial epilepsies","volume":"41","author":"Dizdarer","year":"2000","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD011412.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.seizure.2007.05.006","article-title":"The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures","volume":"16","author":"Donati","year":"2007","journal-title":"Seizure"},{"issue":"10","key":"10.1002\/14651858.CD011412.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.braindev.2012.03.006","article-title":"Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy","volume":"34","author":"Eun","year":"2012","journal-title":"Brain & Development"},{"issue":"8738","key":"10.1002\/14651858.CD011412.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0140-6736(91)91176-U","article-title":"Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group)","volume":"337","author":"Feksi","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1469-8749.1993.tb11616.x","article-title":"Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial","volume":"35","author":"Berg","year":"1993","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1469-8749.1991.tb14917.x","article-title":"Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate","volume":"33","author":"Forsythe","year":"1991","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011412.pub3-BIB0042|cit42","first-page":"157","article-title":"Effects of lamotrigine and oxcarbazepine on seizures, cognition, mood and health-related quality of life in patients with untreated epilepsy","volume":"47","author":"Fritz","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0b013e3180333069","article-title":"Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure","volume":"30","author":"Gilad","year":"2007","journal-title":"Clinical Neuropharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-1211(97)00025-9","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy","volume":"27","author":"Guerreiro","year":"1997","journal-title":"Epilepsy Research"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jnnp.58.1.44","article-title":"Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial","volume":"58","author":"Heller","year":"1995","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"23","key":"10.1002\/14651858.CD011412.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1212\/WNL.0000000000001661","article-title":"Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy","volume":"84","author":"Jung","year":"2015","journal-title":"Neurology"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD011412.pub3-BIB0047|cit47","first-page":"47","article-title":"Open, multicenter, randomised comparison of cognitive effects of lamotrigine and slow-release carbamazepine monotherapy in newly diagnosed patients with epilepsy","volume":"43","author":"Kalviainen","year":"2002","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011412.pub3-BIB0048|cit48","first-page":"39-40, Abstract","article-title":"Cognitive side effects of levetiracetam in monotherapy: comparison with carbamazepine and valproate","volume":"48","author":"Kopp","year":"2007","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0049|cit49","first-page":"27","article-title":"An open, randomized, multicenter comparative clinical trial of lamotrigine and carbamazepine as initial monotherapy in previously untreated epilepsies","volume":"12","author":"Korean Lamotrigine Study Group","year":"2008","journal-title":"Journal of Korean Epilepsy Society"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.yebeh.2009.01.010","article-title":"Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study","volume":"14","author":"Kwan","year":"2009","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0051|cit51","first-page":"399, Abstract n","article-title":"Effect of seizures on cognition, behavior, and quality of life during carbamazepine or lamotrigine monotherapy in patients with newly diagnosed partial epilepsy","volume":"11(Suppl 1)","author":"Ju","year":"2011","journal-title":"Epilepsy currents \/ American Epilepsy Society"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.seizure.2010.10.006","article-title":"Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy","volume":"20","author":"Lee","year":"2011","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.yebeh.2015.10.020","article-title":"The effect of recurrent seizures on cognitive, behavioral, and quality-of-life outcomes after 12 months of monotherapy in adults with newly diagnosed or previously untreated partial epilepsy","volume":"53","author":"Lee","year":"2015","journal-title":"Epilepsy & Behavior"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD011412.pub3-BIB0054|cit54","first-page":"278","article-title":"Comparison of valproate and lamotrigine for the treatment of newly diagnosed epilepsy: interim report","volume":"46","author":"Lukic","year":"2005","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group","volume":"327","author":"Mattson","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1528-1157.1987.tb03623.x","article-title":"Carbamazepine versus phenobarbital for partial onset seizures in children","volume":"28","author":"Mitchell","year":"1987","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0058|cit58","first-page":"154","article-title":"Aspects of antiepileptic drug therapy in children","volume":"22","author":"Miura","year":"1990","journal-title":"No to Hattatsu [Brain & Development]"},{"issue":"9","key":"10.1002\/14651858.CD011412.pub3-BIB0059|cit59","first-page":"568","article-title":"Levetiracetam and lamotrigine in old aged onset of epilepsy: a randomized double-blind clinical trial","volume":"71","author":"Motamedi","year":"2013","journal-title":"Tehran University Medical Journal"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0060|cit60","unstructured":"NCT01498822 Levetiracetam versus oxcarbazepine as monotherapy to evaluate efficacy and safety in subjects with partial epilepsy ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0061|cit61","unstructured":"NCT01954121 Open-label, randomized, active-controlled study of LEV used as monotherapy in patients with partial-onset seizures ClinicalTrials.gov"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(01)00271-6","article-title":"A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy","volume":"46","author":"Nieto-Barrera","year":"2001","journal-title":"Epilepsy Research"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0063|cit63","first-page":"18","article-title":"Cognitive effects of anti-epileptic drugs in Nigerians with epilepsy","volume":"24","author":"Ogunrin","year":"2005","journal-title":"African Journal of Neurological Sciences"},{"issue":"9095","key":"10.1002\/14651858.CD011412.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0140-6736(97)06250-8","article-title":"Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India","volume":"351","author":"Pal","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0920-1211(93)90048-C","article-title":"Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment","volume":"14","author":"Placencia","year":"1993","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2003.00093.x","article-title":"Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy","volume":"107","author":"Privitera","year":"2003","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/08830738040190020901","article-title":"Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy","volume":"19","author":"Wheless","year":"2004","journal-title":"Journal of Child Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1994.tb01640.x","article-title":"Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients","volume":"89","author":"Pulliainen","year":"1994","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/WNL.33.7.904","article-title":"A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults","volume":"33","author":"Ramsay","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0896-6974(05)80021-0","article-title":"Efficacy and safety of valproic acid versus phenytoin as sole therapy for newly diagnosed primary generalized tonic-clonic seizures","volume":"5","author":"Ramsay","year":"1992","journal-title":"Journal of Epilepsy"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.33.11.1474","article-title":"Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures","volume":"33","author":"Wilder","year":"1983","journal-title":"Neurology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD011412.pub3-BIB0072|cit72","first-page":"36","article-title":"Results of a randomized double-blind comparison of levetiracetam and carbamazepine in new onset seizures in a geriatric population","volume":"48","author":"Ramsay","year":"2007","journal-title":"Epilepsia"},{"issue":"10","key":"10.1002\/14651858.CD011412.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/j.1528-1167.2010.02670.x","article-title":"Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial","volume":"51","author":"Ramsay","year":"2010","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD011412.pub3-BIB0074|cit74","first-page":"606","article-title":"Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy","volume":"39","author":"Rastogi","year":"1991","journal-title":"Journal of the Association of Physicians of India"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0075|cit75","first-page":"186","article-title":"Comparative cognitive effects of phenytoin and carbamazepine in adult epileptics","volume":"43","author":"Ravi Sudhir","year":"1995","journal-title":"Neurology India"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0076|cit76","first-page":"201","article-title":"A randomised open trial comparing monotherapy with topiramate versus carbamazepine in the treatment of paediatric patients with recently diagnosed epilepsy","volume":"39","author":"Resendiz-Aparicio","year":"2004","journal-title":"Revista de Neurologia"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0920-1211(95)00085-2","article-title":"A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy","volume":"23","author":"Reunanen","year":"1996","journal-title":"Epilepsy Research"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.57.6.682","article-title":"A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group","volume":"57","author":"Richens","year":"1994","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","article-title":"New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine","volume":"64","author":"Rowan","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2007.01128.x","article-title":"An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly","volume":"48","author":"Saetre","year":"2007","journal-title":"Epilepsia"},{"issue":"9566","key":"10.1002\/14651858.CD011412.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"9566","key":"10.1002\/14651858.CD011412.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1981.tb04330.x","article-title":"Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy","volume":"22","author":"Shakir","year":"1981","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0896-6974(05)80133-1","article-title":"Safety and efficacy of valproate and carbamazepine in the treatment of complex partial seizures","volume":"5","author":"So","year":"1992","journal-title":"Journal of Epilepsy"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1528-1157.1999.tb05562.x","article-title":"Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin","volume":"40","author":"Steiner","year":"1999","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD011412.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.seizure.2005.09.011","article-title":"The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults","volume":"14","author":"Steinhoff","year":"2005","journal-title":"Seizure"},{"issue":"2-3","key":"10.1002\/14651858.CD011412.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.eplepsyres.2007.04.009","article-title":"Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy","volume":"75","author":"Stephen","year":"2007","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"Article ID 4150","DOI":"10.1155\/2015\/415082","article-title":"Efficacy and safety of levetiracetam and carbamazepine as monotherapy in partial seizures","volume":"2015","author":"Suresh","year":"2015","journal-title":"Epilepsy research and treatment"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0089|cit89","first-page":"549","article-title":"Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study","volume":"33","author":"Thilothammal","year":"1996","journal-title":"Indian Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD011412.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jnnp-2011-300376","article-title":"KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy","volume":"84","author":"Trinka","year":"2013","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"6471","key":"10.1002\/14651858.CD011412.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bmj.290.6471.815","article-title":"Which drug for the adult epileptic patient: phenytoin or valproate?","volume":"290","author":"Turnbull","year":"1985","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jnnp.45.1.55","article-title":"A comparison of phenytoin and valproate in previously untreated adult epileptic patients","volume":"45","author":"Turnbull","year":"1982","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1059-1311(97)80065-9","article-title":"Weight gain with valproate or carbamazepine - a reappraisal","volume":"6","author":"Easter","year":"1997","journal-title":"Seizure"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-8749.1995.tb11978.x","article-title":"A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group","volume":"37","author":"Verity","year":"1995","journal-title":"Developmental Medicine & Child Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0095|cit95","first-page":"49, Abstract no","article-title":"Levetiracetam is superior to carbamazepine-SR in newly diagnosed epilepsy in the elderly: results of the step-one trial","volume":"53 Suppl. 5","author":"Werhahn","year":"2012","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/epi.12926","article-title":"A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy","volume":"56","author":"Werhahn","year":"2015","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0097|cit97","first-page":"S159-S60, Abstr","article-title":"Comparative effectiveness of the antiepileptic drugs (AEDs) levetiracetam, valproate and carbamazepine among patients aged 60 years and over with newly diagnosed epilepsy","volume":"261(Suppl 1)","author":"Wild","year":"2014","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10072-006-0663-2","article-title":"Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine","volume":"27","author":"Albani","year":"2006","journal-title":"Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1525-5050(02)00516-4","article-title":"Levetiracetam monotherapy for adults with localization-related epilepsy","volume":"3","author":"Alsaadi","year":"2002","journal-title":"Epilepsy and Behavior"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.seizure.2004.12.006","article-title":"Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study","volume":"14","author":"Alsaadi","year":"2005","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0101|cit101","unstructured":"Baxter L Cheesbrough A An open randomised comparison of Lamictal (lamotrigine) with physicians preferred choice of either valproate or carbamazepine as monotherapy in patients over 12 years of age with newly diagnosed epilepsy Clinical summary report 1998"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011412.pub3-BIB0102|cit102","first-page":"S51","article-title":"Preliminary efficacy of levetiracetam in monotherapy","volume":"5","author":"Ben-Menachem","year":"2003","journal-title":"Epileptic Disorders"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1212\/WNL.49.3.746","article-title":"Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82\/83","volume":"49","author":"Beydoun","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1528-1157.1998.tb01357.x","article-title":"Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy","volume":"39","author":"Beydoun","year":"1998","journal-title":"Epilepsia"},{"issue":"12","key":"10.1002\/14651858.CD011412.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.54.12.2245","article-title":"Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial","volume":"54","author":"Beydoun","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0920-1211(93)90029-7","article-title":"Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function","volume":"16","author":"Bittencourt","year":"1993","journal-title":"Epilepsy Research"},{"issue":"2-3","key":"10.1002\/14651858.CD011412.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0920-1211(98)00088-6","article-title":"The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy","volume":"33","author":"Bawden","year":"1999","journal-title":"Epilepsy Research"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1212\/WNL.24.5.401","article-title":"Carbamazepine for epilepsy. A controlled prospective evaluation","volume":"24","author":"Cereghino","year":"1974","journal-title":"Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD011412.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.eplepsyres.2012.03.007","article-title":"Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study","volume":"101","author":"Chung","year":"2012","journal-title":"Epilepsy Research"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007691-200012000-00017","article-title":"Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial","volume":"22","author":"DeToledo","year":"2000","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0111|cit111","unstructured":"EUCTR2004-004053-26-SE An explorative use open-label, multi-center, randomized trial studying the safety and efficacy of levetiracetam (500 mg\/day to 3000 mg\/day) and valproate (600 mg\/day to 3000 mg\/day) as monotherapy in newly diagnosed patients over the age of 65 years - Scandinavian elderly study www.clinicaltrialsregister.eu"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0112|cit112","unstructured":"EUCTR2010-018284-42-NL A trial comparing efficacy, safety and tolerance between levetiracetam and valproic acid in children with epilepsy www.clinicaltrialsregister.eu"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.yebeh.2004.04.006","article-title":"Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy","volume":"5","author":"Fakhoury","year":"2004","journal-title":"Epilepsy & Behavior"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13311-011-0088-3","article-title":"Lamotrigine XR conversion to monotherapy: first study using a historical control group","volume":"9","author":"French","year":"2012","journal-title":"Neurotherapy"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.51.4.1018","article-title":"An active-control trial of lamotrigine monotherapy for partial seizures","volume":"51","author":"Gilliam","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cpt19623123","article-title":"Comparison of the effectiveness of phenobarbital, mephobarbital, primidone, dipheylhydantoin, ethotoin, metharbital, and methylphenylhydantion in motor seizures","volume":"3","author":"Gruber","year":"1962","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00223-016-0109-7","article-title":"Monotherapy with levetiracetam versus older AEDs: a randomized comparative trial of effects on bone health","volume":"98","author":"Hakami","year":"2016","journal-title":"Calcified Tissue International"},{"issue":"12","key":"10.1002\/14651858.CD011412.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archneurol.2012.2203","article-title":"Substitution monotherapy with levetiracetam vs older antiepileptic drugs: a randomized comparative trial","volume":"69","author":"Hakami","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0119|cit119","unstructured":"ISRCTN73223855 A randomised controlled trial of phenobarbitone and phenytoin for newly diagnosed epilepsy in adults www.isrctn.com"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.yebeh.2003.08.033","article-title":"Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy","volume":"4","author":"Kaminow","year":"2003","journal-title":"Epilepsy & Behavior"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011412.pub3-BIB0121|cit121","first-page":"17","article-title":"Switching patients to monotherapy: efficacy and tolerability for Lamictal(r) compared to valproate","volume":"6","author":"Kerr","year":"1999","journal-title":"European Journal of Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011412.pub3-BIB0122|cit122","first-page":"S291","article-title":"Lamotrigine compared to valproate: a randomised open label switch to monotherapy study in patients with uncontrolled epilepsy","volume":"187","author":"Kerr","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"6-7","key":"10.1002\/14651858.CD011412.pub3-BIB0123|cit123","first-page":"434","article-title":"Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine","volume":"140","author":"Loiseau","year":"1984","journal-title":"Revue Neurologique"},{"issue":"Suppl 98","key":"10.1002\/14651858.CD011412.pub3-BIB0124|cit124","first-page":"89","article-title":"Substitution of diphenylhydantoin by oxcarbazepine or carbamazepine: double-blind study","volume":"69","author":"Reinikainen","year":"1984","journal-title":"Acta Neurologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0920-1211(87)90003-9","article-title":"Comparison of oxcarbazepine and carbamazepine: a double-blind study","volume":"1","author":"Reinikainen","year":"1987","journal-title":"Epilepsy Research"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/jnnp-2011-301999","article-title":"The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study","volume":"83","author":"Rosenow","year":"2012","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"41","key":"10.1002\/14651858.CD011412.pub3-BIB0127|cit127","first-page":"2392","article-title":"Carbamazepine versus diphenylhydantoin in psychomotor epilepsy. A double blind study of antiepileptic effect and side effects","volume":"137","author":"Simonsen","year":"1975","journal-title":"Ugeskrift for Laeger"},{"issue":"Suppl 60","key":"10.1002\/14651858.CD011412.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0404.1975.tb01386.x","article-title":"A double blind study of carbamazepine and diphenylhydantoin in temporal lobe epilepsy","volume":"52","author":"Simonsen","year":"1975","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0129|cit129","first-page":"209","article-title":"Is oxcarbazepine better than phenytoin for the treatment of dementia patients complicated with secondary epilepsy? A comparative study","volume":"28","author":"Taragano","year":"2003","journal-title":"Revista Neurologica Argentina"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0130|cit130","first-page":"340","article-title":"Clinical efficacy of oxcarbazepine suspension in children with focal epilepsy","volume":"15","author":"Chen","year":"2013","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"10","key":"10.1002\/14651858.CD011412.pub3-BIB0131|cit131","first-page":"730","article-title":"Clinical observation of oxcarbazepine suspension monotherapy for 2 to 4-year-old patients newly diagnosed as partial epilepsy","volume":"45","author":"Chen","year":"2012","journal-title":"Chinese Journal of Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0132|cit132","unstructured":"IRCT201202068943N1 Efficacy of oxcarbazepine and phenytoin in control of epilepsy in the elderly www.irct.ir\/searchresult.php?id=8943&number=1"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0133|cit133","first-page":"50","article-title":"Double-blind, randomized, comparative clinical trial of zonisamide and carbamazepine as initial monotherapy in newly diagnosed epilepsy","volume":"3","author":"Korean Zonisamide Study Group","year":"1999","journal-title":"Journal of Korean Epilepsy Society"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0134|cit134","unstructured":"NCT00154076 A multicenter comparative trial of zonisamide and topiramate as initial monotherapy in untreated epilepsies ClinicalTrials.gov"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0135|cit135","first-page":"65","article-title":"Safety and efficacy of topiramate monotherapy in children with recent-onset seizures","volume":"5","author":"Park","year":"2001","journal-title":"Journal of Korean Epilepsy Society"},{"issue":"4-5","key":"10.1002\/14651858.CD011412.pub3-BIB0136|cit136","first-page":"79","article-title":"Effect of monotherapy with phenytoin or carbamazepine on somatosensory evoked potentials in patients with newly diagnosed epilepsy","volume":"49","author":"Rysz","year":"1994","journal-title":"Polski Tygodnik Lekarski"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0137|cit137","first-page":"1265","article-title":"Comparative study for retention rate of new antiepileptic drugs as an initial monotherapy in complex partial epilepsy","volume":"21","author":"Xu","year":"2012","journal-title":"Chinese Journal of New Drugs"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0138|cit138","unstructured":"ACTRN12615000556549 EpiNet-First Trial 2: comparison of efficacy of levetiracetam and sodium valproate in people with previously untreated epilepsy who have generalised seizures In: Auckland District Health B, editor. 2015"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0139|cit139","unstructured":"ACTRN12615000639527 EpiNet-First Trial 3: comparison of efficacy of levetiracetam and lamotrigine in people with previously untreated epilepsy who have generalised seizures, and for whom sodium valproate is not deemed an acceptable anti-epileptic drug In: Auckland District Health B, editor. 2015"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0140|cit140","unstructured":"ACTRN12615000640505 EpiNet-First Trial 4: comparison of efficacy of levetiracetam, lamotrigine and sodium valproate in people with previously untreated epilepsy who have unclassified seizures In: Auckland District Health B, editor. 2015"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0141|cit141","unstructured":"ACTRN12615000641594 EpiNet-First Trial 5: comparison of efficacy of levetiracetam and lamotrigine in people with previously untreated epilepsy who have unclassified seizures, and for whom sodium valproate is not deemed an acceptable anti-epileptic drug In: Auckland District Health B, editor. 2015"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0142|cit142","unstructured":"ACTRN12615000643572 EpiNet-First Trial 1: comparison of efficacy of levetiracetam, lamotrigine and carbamazepine in people with previously untreated epilepsy who have focal seizures In: Auckland District Health B, editor. 2015"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0143|cit143","unstructured":"NCT01891890 Cognitive AED outcomes in pediatric localization related epilepsy (COPE) ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0144|cit144","unstructured":"NCT02201251 A study to investigate the safety of the drugs topiramate and levetiracetam in treating children recently diagnosed with epilepsy ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/bjc.1995.364","article-title":"Review of survival analyses published in cancer journals","volume":"72","author":"Altman","year":"1995","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1528-1157.1999.tb00748.x","article-title":"The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintenance organizations","volume":"40","author":"Annegers","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011412.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1528-1157.1987.tb05769.x","article-title":"Monotherapy with valproate in primary generalized epilepsies","volume":"28","author":"Bourgeois","year":"1987","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199601183340308","article-title":"Antiepileptic drugs","volume":"334","author":"Brodie","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD011412.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1528-1157.1999.tb00851.x","article-title":"Malformations in offspring of women with epilepsy: a prospective study","volume":"40","author":"Canger","year":"1999","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1528-1157.1992.tb02330.x","article-title":"Phenytoin-folate interactions: differing effects of the sodium salt and the free acid of phenytoin","volume":"33","author":"Carl","year":"1992","journal-title":"Epilepsia"},{"issue":"8968","key":"10.1002\/14651858.CD011412.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011412.pub3-BIB0157|cit157","first-page":"123","article-title":"Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons","volume":"34","author":"Coulter","year":"1993","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.34.3.285","article-title":"Juvenile myoclonic epilepsy of Janz","volume":"34","author":"Delgado-Escueta","year":"1984","journal-title":"Neurology"},{"issue":"(7-8)","key":"10.1002\/14651858.CD011412.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0160|cit160","unstructured":"Electronic Medicines Compendium (eMC) www.medicines.org.uk\/emc\/"},{"issue":"suppl","key":"10.1002\/14651858.CD011412.pub3-BIB0161|cit161","first-page":"P173","article-title":"Effect of zonisamide on neurotransmitter in mouse brain","volume":"20","author":"Endoh","year":"1994","journal-title":"Neurosciences"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0162|cit162","first-page":"1488","article-title":"Antiepileptic Drugs","volume-title":"Epilepsy: A Comprehensive Textbook","volume":"3","author":"Engel","year":"2008"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0163|cit163","unstructured":"Epilepsy Foundation of America Inc Seizure and Epilepsy Medicines www.epilepsy.com\/learn\/treating-seizures-and-epilepsy\/seizure-and-epilepsy-medicines?gclid=COarmvHni7kCFXLJtAodYREA1w"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1155\/1990\/917164","article-title":"Metabolic characteristics of oxcarbazepine (Trileptal) and their beneficial implications for enzyme induction and drug interactions","volume":"3","author":"Faigle","year":"1990","journal-title":"Behaviour Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0165|cit165","unstructured":"U.S. Food and Drug Administration www.fda.gov\/"},{"issue":"8","key":"10.1002\/14651858.CD011412.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","article-title":"Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1212\/01.CON.0000284529.35649.1d","article-title":"Appendix C: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"13","author":"French","year":"2007","journal-title":"CONTINUUM Lifelong Learning in Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD011412.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2006.02.022","article-title":"Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein","volume":"536","author":"Gillard","year":"2006","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0890-6238(92)90181-R","article-title":"Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study","volume":"6","author":"Gladstone","year":"1992","journal-title":"Reproductive Toxicology"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GRADE Working Group","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0026-895X(25)08760-7","article-title":"Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin","volume":"47","author":"Granger","year":"1995","journal-title":"Molecular Pharmacology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00003495-199243060-00007","article-title":"Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders","volume":"43","author":"Grant","year":"1992","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneur.1993.00540060034013","article-title":"Juvenile myoclonic epilepsy: a review","volume":"50","author":"Gr\u00fcnewald","year":"1993","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935 - 1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0178|cit178","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0922-4106(93)90156-4","article-title":"Localization of [3H] gabapentin to a novel site in rat brain: autoradiographic studies","volume":"244","author":"Hill","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the \"common\" neurologic disorders?","volume":"68","author":"Hirtz","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1528-1157.1998.tb01167.x","article-title":"Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy","volume":"39","author":"ILAE Commission on Antiepileptic Drugs","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/sim.5453","article-title":"Quantifying the impact of between-study heterogeneity in multivariate meta-analyses","volume":"31","author":"Jackson","year":"2012","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1469-8749.1977.tb08015.x","article-title":"Treatment of generalized epilepsies of childhood and adolescence with sodium valproate","volume":"19","author":"Jeavons","year":"1977","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children","volume":"79","author":"Joseph","year":"2015 Mar","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1157.1983.tb04893.x","article-title":"Natural history of epileptic seizures","volume":"24","author":"Juul-Jenson","year":"1983","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0187|cit187","first-page":"115","article-title":"Effect of zonisamide on release of aspartic acid and gamma-aminobutyric acid from the hippocampal slices of E1 mice","volume":"20","author":"Kawai","year":"1994","journal-title":"Neurosciences"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(93)91660-K","article-title":"Studies on the mechanism of action of the novel anti-convulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex","volume":"612","author":"Lees","year":"1993","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0191|cit191","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1528-1157.1994.tb02549.x","article-title":"Absence seizures and carbamazepine in adults","volume":"35","author":"Liporace","year":"1994","journal-title":"Epilepsia"},{"issue":"474","key":"10.1002\/14651858.CD011412.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0194|cit194","doi-asserted-by":"crossref","unstructured":"Lynch BA Lambeng N Nocka K Kensel-Hammes P Bajjalieh SM Matagne A The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam National Academy of Sciences of the United States of America 2004 9861 6","DOI":"10.1073\/pnas.0308208101"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U","article-title":"Factors predicting prognosis of epilepsy after presentation with seizures","volume":"48","author":"MacDonald","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0196|cit196","volume-title":"Idiopathic Generalised Epilepsies: Clinical, Experimental and Genetic","author":"Malafosse","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0197|cit197","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001030","article-title":"Carbamazepine versus valproate monotherapy for epilepsy","author":"Marson","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011412.pub3-BIB0198|cit198","first-page":"72","article-title":"Gabapentin","volume":"36","author":"McClean","year":"1995","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","article-title":"Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture","volume":"237","author":"McLean","year":"1986","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD011412.pub3-BIB0200|cit200","first-page":"S39-50; discuss","article-title":"Gabapentin in the management of convulsive disorders","volume":"40","author":"McLean","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Research"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0202|cit202","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"Journal of Neurology, Neurosurgery and Neuropsychiatry"},{"issue":"12","key":"10.1002\/14651858.CD011412.pub3-BIB0204|cit204","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012065.pub2","article-title":"Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review","author":"Nevitt","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0206|cit206","unstructured":"National Institute for Health and Care Excellence The epilepsies: the diagnosis and management of the epilepsies in adults and children and primary and secondary care. NICE guidelines [CG137] Published date: January 2012 Available from www.nice.org.uk\/guidance\/cg137"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0207|cit207","unstructured":"National Institute of Neurological Disorders and Stroke (NINDS) The epilepsies and seizures: hope through research www.ninds.nih.gov\/disorders\/epilepsy\/curing_the_epilepsies_brochure.pdf"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0208|cit208","unstructured":"Nolan SJ Sutton L Marson A Tudur Smith C Consistency of outcome and statistical reporting of time-to-event data: the impact on Cochrane Reviews and meta-analyses in epilepsy 21st Cochrane Colloquium: Better Knowledge for Better Health Quebec City 2013 114 5"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0209|cit209","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002217.pub2","article-title":"Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures","author":"Nolan","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0210|cit210","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003615.pub3","article-title":"Oxcarbazepine versus phenytoin monotherapy for epilepsy","author":"Nolan","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD011412.pub3-BIB0211|cit211","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001911.pub2","article-title":"Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review","author":"Nolan","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0212|cit212","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001031.pub3","article-title":"Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review","author":"Nolan","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011412.pub3-BIB0213|cit213","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001904.pub3","article-title":"Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review","author":"Nolan","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0214|cit214","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001769.pub3","article-title":"Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review","author":"Nolan","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1096-8628(19970110)68:1<18::AID-AJMG4>3.0.CO;2-U","article-title":"Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications","volume":"68","author":"Nulman","year":"1997","journal-title":"American Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.bjp.0701941","article-title":"Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode","volume":"124","author":"Okada","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1474-4422(05)70172-1","article-title":"Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study","volume":"4","author":"Olafsson","year":"2005","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011412.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reproductive Toxicology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0219|cit219","volume-title":"Meta-Analysis in Stata: An Updated Collection from the Stata Journal, Second Edition","author":"Palmer","year":"2016"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1157.1989.tb05833.x","article-title":"Juvenile myoclonic epilepsy: long term response to therapy","volume":"30","author":"Penry","year":"1989","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197713020-00001","article-title":"Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy","volume":"13","author":"Pinder","year":"1977","journal-title":"Drugs"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0223|cit223","first-page":"756","article-title":"Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs","volume":"40","author":"Ragsdale","year":"1991","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011412.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/jphysiol.1996.sp021784","article-title":"Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons","volume":"497","author":"Rho","year":"1996","journal-title":"Journal of Physiology"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.0013-9580.2004.11403.x","article-title":"Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures","volume":"45","author":"Sackellares","year":"2004","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","journal-title":"PloS one"},{"issue":"5","key":"10.1002\/14651858.CD011412.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","article-title":"Epidemiology of the epilepsies","volume":"61","author":"Sander","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011412.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0013-9580.2004.455005.x","article-title":"The use of anti-epileptic drugs - principles and practice","volume":"45","author":"Sander","year":"2004","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0229|cit229","unstructured":"SAS Institute Inc Base SAS 2011"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(87)90168-5","article-title":"Zonisamide enhances slow sodium inactivation in Myxicola","volume":"413","author":"Schauf","year":"1987","journal-title":"Brain Research"},{"issue":"3","key":"10.1002\/14651858.CD011412.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D32197W4T4","article-title":"Phenytoin in cutaneous medicine: its uses, mechanisms and side effects","volume":"9","author":"Scheinfeld","year":"2003","journal-title":"Dermatology Online Journal"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0232|cit232","first-page":"7","article-title":"Sodium valproate, phenytoin and carbamazepine as sole anticonvulsants","volume-title":"The place of sodium valproate in the treatment of epilepsy","author":"Shakir","year":"1980"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.33.11.1487","article-title":"Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children","volume":"33","author":"Shields","year":"1983","journal-title":"Neurology"},{"issue":"15","key":"10.1002\/14651858.CD011412.pub3-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM198510103131503","article-title":"Exacerbation of seizures in children by carbamazepine","volume":"313","author":"Snead","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0235|cit235","unstructured":"StataCorp LP Stata Statistical Software: Release 14 2015"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-1211(92)90087-A","article-title":"Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex","volume":"12","author":"Suzuki","year":"1992","journal-title":"Epilepsy Research"},{"issue":"7","key":"10.1002\/14651858.CD011412.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformation with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011412.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1528-1157.1988.tb05805.x","article-title":"Children of school age: the influence of antiepileptic drugs on behavior and intellect","volume":"29","author":"Trimble","year":"1988","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD011412.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1745-6215-8-34","article-title":"Multiple treatment comparisons in epilepsy monotherapy trials","volume":"5","author":"Tudur Smith","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0240|cit240","volume-title":"National Society of Epilepsy Guidelines","author":"Wallace","year":"1997"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0241|cit241","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010224.pub2","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","author":"Weston","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-1211(97)00045-4","article-title":"Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold","volume":"28","author":"White","year":"1997","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0243|cit243","doi-asserted-by":"crossref","unstructured":"White IR Multivariate random-effects meta-analysis Stata Journal 2009 40 56","DOI":"10.1177\/1536867X0900900103"},{"issue":"4","key":"10.1002\/14651858.CD011412.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0245|cit245","unstructured":"World Health Organization Global comparative assessments in the health sector: disease burden, expenditures and intervention packages. Collected reprints from the Bulletin of the World Health Organization. 1994 Available from apps.who.int\/iris\/handle\/10665\/41177 (accessed 13 June 2017)"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0246|cit246","first-page":"339","article-title":"Phenytoin: clinical use","volume-title":"Antiepileptic drugs","author":"Wilder","year":"1995"},{"issue":"11","key":"10.1002\/14651858.CD011412.pub3-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/sim.1303","article-title":"Aggregate data meta-analysis with time-to-event outcomes","volume":"21","author":"Williamson","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0026-895X(25)12546-7","article-title":"Voltage clamp analysis of the inhibitory actions of diphenyihydantoin and carbamazepine on voltage sensitive sodium channels in neuroblastoma cells","volume":"27","author":"Willow","year":"1985","journal-title":"Molecular Pharamcology"},{"key":"10.1002\/14651858.CD011412.pub3-BIB0249|cit249","first-page":"650","article-title":"Antiepileptic Medications","volume-title":"The Treatment of Epilepsy: Principles & Practice","author":"Wyllie","year":"2006"},{"issue":"suppl 7","key":"10.1002\/14651858.CD011412.pub3-BIB0250|cit250","first-page":"245","article-title":"Zonisamide depresses excitatory synaptic transmission by a presynaptic action","volume":"40","author":"Zhu","year":"1999","journal-title":"Epilepsia"},{"issue":"12","key":"10.1002\/14651858.CD011412.pub3-BIB0251|cit251","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis","author":"Nolan","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011412.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011412.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T10:30:47Z","timestamp":1751193047000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011412.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":251,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011412.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD011412.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}